Edited By: Dr. Miquel Lozano
Journal list menu
Vox Sanguinis is the official journal of the International Society of Blood Transfusion. We report on novel developments in transfusion medicine, publishing original papers, reviews, short reports and international fora on all aspects of blood transfusion and cellular therapies.
Following the introduction of our new article layout, and scientific illustrations to accompany reviews, we're delighted to announce more exciting improvements to Vox Sanguinis for 2022:
- More issues – Vox Sanguinis will now publish an issue every month
- Faster publication – the move to monthly issues means that we can publish content in print more rapidly
- Additional sections – we are delighted to welcome two new Section Editors to the team; Claudia Cohn, University of Minnesota will oversee Haemovigilance and Nelson Tsuno, University of Tokyo will lead the Patient Blood Management section
- Removal of colour charges – authors will no longer have to pay to have their colour figures published in print
Reasons to publish with us:
- Offers you a streamlined submission process and free colour figures in print publication.
- The official journal of the ISBT, supported by an international editorial team of 12.
- Get your paper read by transfusion specialists in research and practice, and ISBT members worldwide.
- Advances knowledge via themed issues and new Haemovigilance and Patient Blood Management sections.
Review our Author Guidelines and submit your manuscript.
Publishing Open Access? Your fees may be covered. Check now.
Articles
Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost–utility analysis
-  5 December 2024
Lipaemic plasma: An objective non‐invasive photometric method to classify plasma turbidity and its association with red cell haemolysis
-  2 December 2024
Safety and efficacy of a novel mini‐pool intravenous immunoglobulin therapy in children with primary immunodeficiency
-  1 December 2024
Successful implementation of a patient blood management programme in a lower middle‐income state
-  27 November 2024
Isolation and analysis of residual leucocytes from leucoreduced red blood cell units
-  25 November 2024
International review of blood donation nucleic acid amplification testing
- Vox Sanguinis
-  315-325
-  23 February 2024
Current state of gene therapy in sickle cell disease
- Vox Sanguinis
-  521-528
-  15 March 2024
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
- Vox Sanguinis
-  496-504
-  7 February 2024
A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis
- Vox Sanguinis
-  94-101
-  29 August 2023
Transfusion support and pre‐transfusion testing in autoimmune haemolytic anaemia
- Vox Sanguinis
-  1029-1038
-  23 June 2024
An international review of the characteristics of viral nucleic acid‐amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT
- Vox Sanguinis
-  745-751
-  22 March 2024
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial
- Vox Sanguinis
-  134-143
-  24 November 2023
Blood donation screening for hepatitis B virus core antibodies: The importance of confirmatory testing and initial implication for rare blood donor groups
- Vox Sanguinis
-  447-459
-  28 February 2024
Detection and phenotype analysis of a novel Ael blood group allele
- Vox Sanguinis
-  74-78
-  8 November 2023
Plasma collection and supply in Europe: Proceedings of an International Plasma and Fractionation Association and European Blood Alliance symposium
- Vox Sanguinis
-  798-806
-  18 July 2023
Recommendations for in vitro evaluation of blood components collected, prepared and stored in non-DEHP medical devices
- Vox Sanguinis
-  165-177
-  12 December 2022
Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt–Jakob disease
- Vox Sanguinis
-  345-353
-  7 March 2023
Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men
- Vox Sanguinis
-  440-446
-  14 May 2023
Evolving the gay, bisexual and other men who have sex with men time‐based deferral to sexual risk screening for all donors: The contribution of Canadian research programmes
- Vox Sanguinis
-  605-615
-  16 May 2023
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trial
- Vox Sanguinis
-  134-143
-  24 November 2023
End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral
- Vox Sanguinis
-  388-401
-  25 January 2024
Limited evidence, lasting decisions: How voluntary non‐remunerated plasma donations can avoid the commercial one‐way street
- Vox Sanguinis
-  529-532
-  14 March 2024